-
Signature
-
Danielle White, Attorney-in-fact for Cyril Perducat
-
Issuer symbol
-
ROK
-
Transactions as of
-
07 Dec 2023
-
Net transactions value
-
-$125,497
-
Form type
-
4
-
Filing time
-
11 Dec 2023, 20:58:49 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ROK |
Common Stock |
Options Exercise |
$0 |
+314 |
+13% |
$0.000000 |
2,805 |
07 Dec 2023 |
Direct |
|
| transaction |
ROK |
Common Stock |
Sale |
$39,066 |
-140 |
-5% |
$279.04 |
2,665 |
08 Dec 2023 |
Direct |
F1, F2 |
| transaction |
ROK |
Common Stock |
Options Exercise |
$0 |
+693 |
+26% |
$0.000000 |
3,358 |
09 Dec 2023 |
Direct |
|
| transaction |
ROK |
Common Stock |
Sale |
$78,026 |
-279 |
-8.3% |
$279.66 |
3,079 |
11 Dec 2023 |
Direct |
F3, F4 |
| transaction |
ROK |
Common Stock |
Sale |
$8,405 |
-30 |
-0.97% |
$280.16 |
3,049 |
11 Dec 2023 |
Direct |
F3, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ROK |
Restricted Stock Units |
Options Exercise |
$0 |
-314 |
-50% |
$0.000000 |
314 |
07 Dec 2023 |
Common Stock |
314 |
|
Direct |
F6, F7 |
| transaction |
ROK |
Restricted Stock Units |
Options Exercise |
$0 |
-693 |
-33% |
$0.000000 |
1,386 |
09 Dec 2023 |
Common Stock |
693 |
|
Direct |
F6, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: